Clearbridge Investments, LLC Immuno Gen, Inc. Transaction History

Clearbridge Investments, LLC

$123 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $2.45 Million - $3.54 Million	-546,522 Reduced 10.17%	4,825,543 $23.1 Million
Q2 2022 Aug 11, 2022	SELL	$3.15 - $5.76 $411,950 - $753,281	-130,778 Reduced 2.38%	5,372,065 $24.2 Million
Q1 2022 May 13, 2022	SELL	$4.26 - $7.48 $1.64 Million - $2.87 Million	-384,087 Reduced 6.52%	5,502,843 $26.2 Million
Q4 2021 Feb 11, 2022	SELL	$4.75 - $7.5 $418,375 - $660,592	-88,079 Reduced 1.47%	5,886,930 $43.7 Million
Q3 2021 Nov 12, 2021	BUY	$5.02 - $6.59 $100,239 - $131,589	19,968 Added 0.34%	5,975,009 $33.9 Million
Q2 2021 Aug 13, 2021	SELL	$5.79 - $8.6 $889,598 - $1.32 Million	-153,644 Reduced 2.52%	5,955,041 $39.2 Million
Q1 2021 May 13, 2021	SELL	$6.5 - $10.53 $5.1 Million - $8.26 Million	-784,243 Reduced 11.38%	6,108,685 $49.5 Million
Q4 2020 Feb 10, 2021	SELL	$3.7 - $7.66 $2.06 Million - $4.27 Million	-557,564 Reduced 7.48%	6,892,928 $44.5 Million
Q3 2020 Nov 12, 2020	SELL	$3.45 - $4.89 $1.01 Million - $1.43 Million	-292,312 Reduced 3.78%	7,450,492 $26.8 Million
Q2 2020 Aug 14, 2020	SELL	$3.32 - $5.34 $1.87 Million - $3.01 Million	-564,260 Reduced 6.79%	7,742,804 $35.6 Million
Q1 2020 May 15, 2020	SELL	$2.12 - $6.8 $1.58 Million - $5.06 Million	-743,805 Reduced 8.22%	8,307,064 $28.3 Million
Q4 2019 Feb 14, 2020	SELL	$2.25 - $5.8 $2.96 Million - $7.62 Million	-1,313,594 Reduced 12.67%	9,050,869 $43.2 Million
Q3 2019 Nov 14, 2019	SELL	$2.22 - $3.39 $220,219 - $336,281	-99,198 Reduced 0.95%	10,364,463 $25.1 Million
Q2 2019 Aug 14, 2019	BUY	$1.8 - $3.3 $2.87 Million - $5.26 Million	1,593,033 Added 17.96%	10,463,661 $0
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $1.12 Million - $2.74 Million	464,147 Added 5.52%	8,870,628 $24 Million
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $1.27 Million - $3.13 Million	322,630 Added 3.99%	8,406,481 $40.4 Million
Q3 2018 Nov 14, 2018	SELL	$8.6 - $11.26 $9.3 Million - $12.2 Million	-1,081,179 Reduced 11.8%	8,083,851 $76.6 Million
Q2 2018 Aug 14, 2018	SELL	$9.52 - $12.15 $3.95 Million - $5.04 Million	-414,419 Reduced 4.33%	9,165,030 $89.2 Million
Q1 2018 May 15, 2018	SELL	$6.7 - $12.95 $10 Million - $19.3 Million	-1,491,916 Reduced 13.48%	9,579,449 $101 Million
Q4 2017 Feb 14, 2018	SELL	$5.07 - $7.92 $1.9 Million - $2.96 Million	-374,246 Reduced 3.27%	11,071,365 $71 Million
Q3 2017 Nov 14, 2017	SELL	$5.4 - $8.47 $7.7 Million - $12.1 Million	-1,426,085 Reduced 11.08%	11,445,611 $87.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	12,871,696	12,871,696 $91.5 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account